Results 231 to 240 of about 181,241 (287)

Safety of anagliptin/metformin combination tablets evaluated by non‐inferiority between pre‐ and post‐serum lactic acid levels in Japanese patients with type 2 diabetes and moderate renal impairment (AMELIO STUDY)

open access: yesJournal of Diabetes Investigation, EarlyView.
To investigate the safety of anagliptin/metformin combination tablets in Japanese patients of type 2 diabetes with moderate renal impairment. This study demonstrates that the fixed‐dose combination of anagliptin and metformin can be used safely in patients with type 2 diabetes complicated by moderate renal dysfunction.
Hiroshi Kajio   +10 more
wiley   +1 more source

Continuous glucose monitoring reveals bimodal glycemic patterns during and outside Capivasertib administration

open access: yesJournal of Diabetes Investigation, EarlyView.
ABSTRACT Capivasertib, an AKT inhibitor, interferes with insulin signaling and can induce hyperglycemia. In this case, we monitored blood glucose fluctuations using continuous glucose monitoring (CGM) during capivasertib administration. During the administration period, a post‐dose increase in blood glucose was observed, peaking approximately 4 h after
Yuya Suzuki   +9 more
wiley   +1 more source

The Multifaceted Importance of Amphibians: Ecological, Biomedical, and Socio-Economic Perspectives. [PDF]

open access: yesBiology (Basel)
Wickramasingha B   +4 more
europepmc   +1 more source

Effects of GLP‐1 Receptor Agonists on Hair Loss and Regrowth: A Systematic Review

open access: yes
International Journal of Dermatology, EarlyView.
Miranda K. Branyiczky   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy